Study of Mechanisms of Anovulation in Polycystic Ovary Syndrome

Study acronym: SOPK
StatusCompleted
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Publications: 1 to 3v2
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
We previously hypothesized that the excess of Anti-Mullerian Hormone (AMH) at the level of ovarian selectable follicles could be involved in the follicular arrest of Polycystic Ovary Syndrome (PCOS), mainly through inhibition of FSH effect on aromatase expression.In this study, we plan to investigate whether a drop in the serum AMH level would be concomitant to the appearance of a dominant follicle induced by administration of mild amounts of exogenous FSH in women with PCOS.
Trial Details
NCT Number NCT00492882
Lead Sponsor University Hospital, Lille
Collaborators: Organon
Conditions
(from sponsor)		 Anovulation
Related terms Anovulation, Polycystic Ovary Syndrome
Enrollment 30 participants
Start Date
Study Completion (estimated)
Updated on ClinicalTrials.gov